Colorectal cancer resource library

    Showing 41–42 of 42 results

    Filtered By:
    First FDA-Approved Treatment for HER2-Positive Colorectal Cancer
    Blog

    First FDA-approved treatment for HER2-positive colorectal cancer

    “Historically, patients with HER2-positive metastatic colorectal cancer who have progressed following frontline therapy have had poor outcomes,” said John Strickler, M.D. and lead investigator of the MOUNTAINEER trial. “The FDA approval of a chemotherapy-free combination regimen that specifically targets HER2 is great news for these patients.”

    Dr. Mielke smiles while working in a research laboratory, wearing a white lab coat and blue gloves as she holds a pipette beside lab equipment.
    Blog

    Where breakthroughs begin: Project Cure CRC spotlight on Dr. Lisa Mielke

    hrough Project Cure CRC, the Alliance is fueling bold, early-stage research with the potential to transform colorectal cancer treatment. Dr. Lisa Mielke’s groundbreaking work explores how the gut’s immune system and nerve signaling influence cancer growth—opening the door to new therapeutic approaches, including repurposed existing drugs. This is what’s possible when promising ideas get the support they need to move forward.

    support group three people

    Get connected with your allies

    There are many ways to find your community through the Alliance. Try one of our online communities.

    Learn More